3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
9
Overweight
4
Obesity
4
Neoplasms
4
Prostatic Neoplasms
3
Motor Activity
3
Colorectal Neoplasms
3
Sleep Wake Disorders
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Ovarian Neoplasms
2
Lymphoma
2
Leukemia
2
Hematopoietic and Lymphoid System Neoplasm
2
Hematologic Neoplasms
2
Fatigue
2
Colonic Neoplasms
2
Weight Loss
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Cancer, Papillary
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Obesity-Related Malignant Neoplasm
1
No Evidence of Disease
1
Neoplasm Metastasis
1
Metastatic Pancreatic Adenocarcinoma
1
Lung Neoplasms
1
Locally Advanced Head and Neck Squamous Cell Carcinoma
1
Leukemia, Myeloid, Acute
1
Kidney Neoplasms
1
Interventions
ruxolitinib
23
Cyclophosphamide
13
Whole-Body Irradiation
10
Tacrolimus
9
Mycophenolic Acid
9
fludarabine phosphate
8
fludarabine
8
Stem Cell Transplantation
8
Specimen Handling
7
Peripheral Blood Stem Cell Transplantation
7
Busulfan
5
Azacitidine
5
navitoclax
4
Sirolimus
4
Melphalan
4
Biopsy
4
luspatercept
3
fedratinib
3
Methotrexate
3
Cyclosporine
3
venetoclax
2
selinexor
2
parsaclisib
2
letermovir
2
itacitinib
2
bomedemstat
2
Injections
2
INCB057643
2
INCB039110
2
Hematopoietic Stem Cell Transplantation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Primary Myelofibrosis
×
Counseling
×
1 year
×
Clear all
No trials found.